Article
Recent progress of aptamer‒drug conjugates in cancer therapy
26 Jan 2023
Abstract excerpt
Aptamers are single-stranded DNA or RNA sequences that can specifically bind with the target protein or molecule via specific secondary structures. Compared to antibody-drug conjugates (ADC), aptamer‒drug conjugate (ApDC) is also an efficient, targeted drug for cancer therapy with a smaller size, higher chemical stability, lower immunogenicity, faster tissue penetration, and facile engineering. Despite all these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
